Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLAN: Lidocaine Infusions in Breast Cancer Surgery
NCT04874038Phase 3Active, not recruiting
- Sponsor
- University Health Network
- Start
- Sep 2021
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of Lidocaine Hydrochloride Injection, without epinephrine in Post-mastectomy pain syndrome (PMPS), postoperative pain, chronic pain, sponsored by University Health Network. Started Sep 2021; status: active, not recruiting.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
Post-mastectomy pain syndrome (PMPS)postoperative painchronic pain
Beyond the preview
Go deeper on NCT04874038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04874038.